This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: National Institute of Health and Medical Research. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Fanny Daniel: Innovator in Ulcerative Colitis Research
Introduction
Fanny Daniel is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the development of animal models for studying ulcerative colitis and its complications. Her innovative work has the potential to advance understanding and treatment options for this challenging condition.
Latest Patents
Fanny Daniel holds a patent for a non-human animal model for ulcerative colitis and its main complications. This invention relates to a transgenic non-human animal model that features a targeted disruption in the IL10 and NOX1 genes. As a result, IL10 and NOX1 are not expressed in the animal, allowing for a more accurate study of ulcerative colitis, primary sclerosing cholangitis, and colorectal cancer.
Career Highlights
Throughout her career, Fanny has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale. Her research has focused on creating models that can help in understanding the complexities of ulcerative colitis and its associated risks.
Collaborations
Fanny has collaborated with notable colleagues, including Eric Ogier-Denis and Xavier Treton. These partnerships have enriched her research and contributed to the advancement of knowledge in her field.
Conclusion
Fanny Daniel's innovative work in developing animal models for ulcerative colitis represents a significant advancement in medical research. Her contributions are paving the way for better understanding and treatment of this condition.